Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026)

Nexalin Technology (NXL) posted Cash from Financing Activities of $138365.0 for Q2 2026, down 81.71% on a QoQ basis from $756421.0 in Q1 2026.

Analysis

Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Cash from Financing Activities for 5 years, with the latest figure at $138365.0 in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $138365.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.2 million, up 14.48% from the prior year.
  • Cash from Financing Activities was $138365.0 for Q2 2026 at Nexalin Technology, down from $756421.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $8.5 million in Q3 2022, with the low at -$200000.0 in Q1 2023.
  • Average Cash from Financing Activities over 4 years is $1.4 million, with a median of $138365.0 recorded in 2026.
  • The largest YoY upside for Cash from Financing Activities was 200100.0% in 2023 against a maximum downside of 200100.0% in 2023.
  • Over 4 years, Cash from Financing Activities stood at $8.5 million in 2022, then plunged by 102.35% to -$200000.0 in 2023, then soared by 361.78% to $523550.0 in 2025, then plunged by 73.57% to $138365.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $138365.0 (Q2 2026), $756421.0 (Q1 2026), and $523550.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -343.00 Mn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -300,000.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -607.30 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -213.50 Mn
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 138,365.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138,365.00
Mar 31, 2026 756,421.00
Dec 31, 2025 523,550.00
Mar 31, 2023 -200,000.00
Sep 30, 2022 8.52 Mn
Jun 30, 2022 -5,000.00
Mar 31, 2022 100.00
Dec 31, 2021 934,443.00